Hoffmeister David F 4

What Happened
David F. Hoffmeister, a director of ICU Medical, reported a combination of a derivative conversion/exercise and a grant on 2026-05-13. The filing shows 1,254 shares reported under code M (exercise/conversion of a derivative) at $0.00 and, separately, a grant/award of 1,475 shares under code A (restricted stock units) at $0.00. Total reported dollar consideration for these entries is $0 (no cash paid or received).

Key Details

• Transaction date: 2026-05-13 (reported on the same date). Filing accession: 0001305975-26-000004.
• Reported entries: M — 1,254 shares acquired @ $0.00 and 1,254 shares disposed @ $0.00 (derivative); A — 1,475 shares acquired @ $0.00 (RSUs).
• Shares owned after transaction: Not disclosed in this Form 4 filing.
• Footnotes: F1 = securities are Restricted Stock Units (RSUs). F2 = no purchase or exercise price for the RSUs. F3 = the RSU awards vest on the anniversary of the grant date or the following annual stockholder meeting, whichever occurs first.
• Timeliness: Reported and filed on 2026-05-13 (appears timely).

Context
Code M indicates exercise or conversion of a derivative instrument; the matching acquired and disposed derivative amounts are reported as derivative activity. Code A represents an award of RSUs, which have no cash purchase price and are subject to vesting per the footnote. These types of filings commonly reflect compensation and option/RSU administration rather than open-market buying or selling by the insider.